Skip to main content
TipRanks
Go Ultimate75% OFF

Cardiff Oncology (CRDF) Financial Statements

1,995 Followers

Cardiff Oncology Financial Overview

Cardiff Oncology's market cap is currently $66.34M. The company's EPS TTM is $-0.55; its P/E ratio is -1.55; Cardiff Oncology is estimated to report earnings on March 4, 2027, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 593.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Gross Profit$ 593.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Operating Income$ -48.96M$ -48.65M$ -45.41M$ -39.90M$ -28.86M
EBITDA$ -44.95M$ -45.03M$ -41.04M$ -38.47M$ -27.84M
Net Income$ -45.85M$ -45.43M$ -41.44M$ -38.70M$ -28.29M
Balance Sheet
Cash & Short-Term Investments$ 58.30M$ 91.75M$ 74.82M$ 105.27M$ 140.82M
Total Assets$ 61.88M$ 97.19M$ 81.64M$ 116.19M$ 149.54M
Total Debt$ 832.00K$ 1.52M$ 2.15M$ 2.71M$ 3.12M
Net Debt$ -16.64M$ -49.95M$ -19.51M$ -13.63M$ -8.82M
Total Liabilities$ 16.50M$ 14.24M$ 11.90M$ 9.85M$ 9.13M
Stockholders' Equity$ 45.39M$ 82.95M$ 69.74M$ 106.34M$ 140.42M
Cash Flow
Free Cash Flow$ -37.97M$ -37.77M$ -31.47M$ -34.71M$ -23.25M
Operating Cash Flow$ -37.92M$ -37.69M$ -30.89M$ -33.82M$ -23.04M
Investing Cash Flow$ 1.34M$ 13.73M$ 36.20M$ 38.15M$ -131.45M
Financing Cash Flow$ 2.58M$ 53.78M$ 0.00$ 75.00K$ 35.45M

Currency in USD

Cardiff Oncology Earnings and Revenue History

-50M-25M025M-12000 %-9000 %-6000 %-3000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Cardiff Oncology Liabilities to Assets

060M120M180M0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Cardiff Oncology Cash Flow

-150M-100M-50M050M100M150M200M201720182019202020212022202320242025OperatingInvestingFinancing

Cardiff Oncology Forecast EPS vs Actual EPS

-0.2-0.2-0.2-0.1-0.1-0.1-0.1Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss